Cytokinetics
CYTK
#2280
Rank
$8.02 B
Marketcap
$65.67
Share price
-1.31%
Change (1 day)
30.30%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2025 (TTM): -$0.76 Billion USD

According to Cytokinetics 's latest financial reports the company's current earnings are $87.21 Million USD. In 2024 the company made an earning of -$0.59 Billion USD a decrease over its 2023 earnings that were of -$0.53 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.76 Billion27.55%
2024 -$0.59 Billion12.03%
2023 -$0.53 Billion35.3%
2022 -$0.39 Billion80.65%
2021 -$0.22 Billion69.15%
2020 -$0.13 Billion4.6%
2019 -$0.13 Billion14.49%
2018 -$0.11 Billion-16.83%
2017 -$0.13 Billion-812.8%
2016 $17.92 M-147.81%
2015 -$37.51 Million156.05%
2014 -$14.65 Million-56.56%
2013 -$33.72 Million-16.48%
2012 -$40.38 Million-15.65%
2011 -$47.87 Million-3.24%
2010 -$49.47 Million-308.68%
2009 $23.7 M-141.87%
2008 -$56.61 Million0.21%
2007 -$56.49 Million-7.91%
2006 -$61.34 Million37.42%
2005 -$44.64 Million16.13%
2004 -$38.44 Million-19.29%
2003 -$47.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
$66.79 M-108.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-$31.06 Million-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-$0.28 Billion-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$8.24 B-1,196.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
$4.41 M-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA